口服尼麦角林对人血小板聚集的抑制作用。一项双盲研究。 - Suppr

Suppr

超能文献

Inhibition of human platelet aggregation by oral administration of nicergoline. A double-blind study.

作者信息

Pogliani E, Volpe A D, Ferrari R, Recalcati P, Praga C

出版信息

Farmaco Prat. 1975 Dec;30(12):630-40.

PMID:1107066

Abstract

摘要

相似文献

Inhibition of human platelet aggregation by oral administration of nicergoline. A double-blind study.口服尼麦角林对人血小板聚集的抑制作用。一项双盲研究。

Farmaco Prat. 1975 Dec;30(12):630-40.

[Nicergoline and platelet aggregation. A review of experimental and clinical studies (author's transl)].[尼麦角林与血小板聚集。实验与临床研究综述（作者译）]

Arzneimittelforschung. 1979;29(8a):1270-6.

[Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].血小板聚集抑制剂作用的超微结构研究（作者译）

Arzneimittelforschung. 1979;29(8a):1278-82.

[Platelet aggregation activity. Inhibitory effects of an alpha-blocking agent: nicergoline].

Sem Hop Ther. 1974 Dec;50(10):649-55.

[Ultrastructural study of the action of a blood platelet anti-aggregant. Application to nicergoline].[血小板抗聚集剂作用的超微结构研究。在尼麦角林中的应用]

Therapie. 1977 Mar-Apr;32(2):205-14.

Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.

Prostaglandins. 1980 Apr;19(4):551-7. doi: 10.1016/s0090-6980(80)80005-0.

[Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].

Arzneimittelforschung. 1979;29(8a):1266-9.

Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.血小板介导的犬冠状动脉狭窄血栓形成：血小板活性α-肾上腺素能拮抗剂尼麦角林的抑制作用

J Am Coll Cardiol. 1984 Jun;3(6):1417-26. doi: 10.1016/s0735-1097(84)80280-6.

[A review of pharmacological studies on nicergoline].[尼麦角林的药理学研究综述]

Arzneimittelforschung. 1979;29(8a):1223-7.

[Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].[尼麦角林在颈-前列腺括约肌病理学中的药理学研究]

Ann Urol (Paris). 1987;21(2):107-14.

引用本文的文献

α-Adrenergic Receptor as a Target for Neurocognition: Cautionary Tale from Nicergoline and Quinazoline Non-Selective Blockers.

Pharmaceuticals (Basel). 2025 Sep 23;18(10):1425. doi: 10.3390/ph18101425.

Safety of nicergoline as an agent for management of cognitive function disorders.尼麦角林作为认知功能障碍治疗药物的安全性。

Biomed Res Int. 2014;2014:610103. doi: 10.1155/2014/610103. Epub 2014 Aug 28.

A systematic review and meta-analysis assessing adverse event profile and tolerability of nicergoline.一项评估尼麦角林不良事件概况和耐受性的系统评价与荟萃分析。

BMJ Open. 2014 Jul 30;4(7):e005090. doi: 10.1136/bmjopen-2014-005090.

Therapeutic use of nicergoline.尼麦角林的治疗用途。

Clin Drug Investig. 2008;28(9):533-52. doi: 10.2165/00044011-200828090-00001.

Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.尼麦角林治疗阿尔茨海默型老年痴呆和多发梗死性痴呆：一项双盲、安慰剂对照的临床及脑电图/事件相关电位图谱研究

Psychopharmacology (Berl). 1995 Feb;117(4):385-95. doi: 10.1007/BF02246209.

Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.肾上腺素对人血小板活化的增强作用以及α-肾上腺素能拮抗剂尼麦角林对血小板黏附、分泌和聚集的抑制作用。

Agents Actions. 1986 Aug;18(5-6):586-95. doi: 10.1007/BF01964968.

Prostaglandin and thromboxane biosynthesis inhibitors.

Naunyn Schmiedebergs Arch Pharmacol. 1977;297 Suppl 1:S85-8. doi: 10.1007/BF00587789.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验